U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07586943) titled 'SKB118 Injection in Advanced Solid Tumors' on May 07.
Brief Summary: This is a phase 1/2 clinical study to evaluate the safety and efficacy of SKB118 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumors
Intervention:
DRUG: SKB118 Injection
SKB118 Injection monotherapy, iv drip, every 3 weeks (Q3W), until radiographic disease progression (PD), intolerable toxicity, death, or discontinuation of treatment, whichever occurs first.
Recruitment Status: ...